Catherine Bird
Senior Clinical Trials Manager at King’s College London
Key Impact
She is a key clinical trials researcher in major psychedelic studies, including psilocybin trials for treatment-resistant depression and related neuropsychiatric conditions.
Background & Research
Catherine Bird works in psychedelic research as part of the Psychoactive Trials Group at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London. She appears on multiple psilocybin and psychedelic clinical trial publications, including studies in depression, headache disorders, and healthy volunteers. Her KCL profile lists her as Senior Clinical Trials Manager based at the Institute of Psychiatry, Psychology & Neuroscience.
Collaboration Network
28 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Safety & Risk ManagementDepressive DisordersTreatment-Resistant Depression (TRD)Major Depressive Disorder (MDD)Healthy VolunteersChronic PainHeadache Disorders (Cluster & Migraine)Anxiety DisordersOlder AdultsMedicinal Chemistry & Drug DevelopmentMicrodosingNeuroimaging & Brain MeasuresEquity and EthicsSuicidalityObsessive-Compulsive Disorder (OCD)Substance Use Disorders (SUD)Palliative & End-of-Life DistressInterpersonal Functioning & Social Connectedness